Effect of mild hypoinsulinemia on renal hypertrophy: Growth hormone/insulin-like growth factor 1 system in mild streptozotocin diabetes

International Journal of Experimental Diabetes Research

Volumn 3, Issue 4, 2002, Pages 257-264

  Khamaisi, Mogher ^a   Flyvbjerg, Allan ^b   Haramati, Ziv ^a   Raz, Gadi ^a   Wexler, Isaiah D ^a   Raz, Itamar ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Diabetic kidney disease; Growth hormone; Hyperfiltration; Insulin like growth factor I; Renomegaly

Indexed keywords

GLUCOSE; GROWTH HORMONE; INSULIN; MESSENGER RNA; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN C; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; EXPERIMENTAL DIABETES MELLITUS; GLOMERULUS FILTRATION; HYPOINSULINEMIA; KIDNEY HYPERTROPHY; KIDNEY SIZE; MALE; METABOLIC DISORDER; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVIEW; STREPTOZOCIN DIABETES;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; FASTING; GROWTH HORMONE; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 4; KIDNEY; MALE; ORGAN SIZE; RATS; RATS, INBRED STRAINS; REFERENCE VALUES; REGRESSION ANALYSIS;

EID: 12244290338     PISSN: 15604284     EISSN: None     Source Type: Journal    
DOI: 10.1080/15604280214937     Document Type: Review

References (26)

1. Raz, I., and Wexler, I. D. (1999) Extrarenal complications of the type 2 diabetes patient with diabetic nephropathy. In: Nephropathy in Type 2 Diabetes, Edited by Ritz, E., and Rychlik, I., pp. 158-194. Oxford, UK, Oxford University Press.
2. Flyvbjerg, A. (1997) Role of growth hormone, insulin-like growth factors (IGFs) and IGF-binding proteins in the renal complications of diabetes. Kidney Int. Suppl., 60, S12-S19.
3. Flyvbjerg, A., Hill, C., and Logan, A. (1999) Pathophysiological role of growth factors in diabetic kidney disease: Focus on innovative therapy. Trends Endocrin. Metab., 10, 267-272.
4. Abboud, H. E. (1997) Growth factors and diabetic nephrology: An overview. Kidney Int. Suppl., 60, S3-S6.
5. Winter, R. J., Phillips, L. S., Klein, M. N., Traisman, H. S., and Green, O. C. (1979) Somatomedin activity and diabetic control in children with insulin-dependent diabetes. Diabetes, 28, 952-954.
6. Flyvbjerg, A., Bornfeldt, K. E., Marshall, S. M., Arnqvist, H. J., and Orskov, H. (1990) Kidney IGF-I mRNA in initial renal hypertrophy in experimental diabetes in rats. Diabetologia, 33, 334-338.
7. Unterman, T. G., Jentel, J. J., Oehler, D. T., Lacson, R. G., and Hofert, J. F. (1993) Effects of glucocorticoids on circulating levels and hepatic expression of insulin-like growth factor (IGF)-binding proteins and IGF-I in the adrenalectomized streptozotocin-diabetic rat. Endocrinology, 133, 2531-2539.
8. Flyvbjerg, A., Frystyk, J., Osterby, R., and Orskov, H. (1992) Kidney IGF-I and renal hypertrophy in GH-deficient diabetic dwarf rats. Am. J. Physiol., 262, E956-E962.
9. Flyvbjerg, A., and Orskov H. (1990) Kidney tissue insulin-like growth factor I and initial renal growth in diabetic rats: Relation to severity of diabetes. Acta Endocrinol. Copenh., 122, 374-378.
10. D'Ercole, A. J., Stiles, A. D., and Underwood, L. E. (1984) Tissue concentrations of somatomedin C: Further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc. Natl. Acad. Sci. U.S.A., 81, 935-939.
11. Weiss, O., Anner, H., Nephesh, I., Alayoff, A., Bursztyn, M., and Raz, I. (1995) Insulin-like growth factor-I (IGF-I) and IGF-I receptor gene expression in the kidney of the chronically hypoinsulinemic rat and hyperinsulinemic rat. Metabolism, 44, 982-986.
12. Pugliese, G., Pricci., F, Locuratolo, N., Romeo, G., Romano, G., Giannini, S., Cresci, B., Galli, G., Rotella, C. M., and Di Mario, U. (1996) Increased activity of the insulin-like growth factor system in mesangial cells cultured in high glucose conditions. Relation to glucose-enhanced extracellular matrix production. Diabetologia, 39, 775-784.
13. Narayanan, S., and Appleton, H. D. (1980) Creatinine: A review. Clin. Chem., 26, 1119-1126.
14. Furlanetto, R. W., and Marino, J. M. (1987) Radioimmunoassay of somatomedin C/insulin-like growth factor I. Methods Enzymol., 146, 216-226.
15. Flyvbjerg, A., Kessler, U., Dorka, B., Funk, B., Orskov, H., and Kiess, W. (1992) Transient increase in renal insulin-like growth factor binding proteins during initial kidney hypertrophy in experimental diabetes in rats. Diabetologia, 35, 589-593.
16. Symon, Z., Fuchs, S., Agmon, Y., Weiss, O., Nephesh, I., Moshe, R., Brezis, M., Flyvbjerg, A., and Raz, I. (1998) The endogenous insulin-like growth factor system in radiocontrast nephropathy. Am. J. Physiol. 274, F490-F497.
17. Werner, H., Woloschak, M., Adamo, M., Shen-Orr, Z., Roberts, C. T. J., and LeRoith, D. (1989) Developmental regulation of the rat insulin-like growth factor I receptor gene. Proc. Natl. Acad. Sci. U.S.A., 86, 7451-7455.
18. Raz, I., Rubinger, D., Popovtzer, M., Gronbaek, H., Weiss, O., and Flyvbjerg, A. (1998) Octreotide prevents the early increase in renal insulin-like growth factor binding protein 1 in streptozotocin diabetic rats. Diabetes, 47, 924-930.
19. Tannenbaum, G. (1981) Growth hormone secretion dynamics in streptozotocin diabetes: Evidence of a role for endogenous somatostatin. Endocrinology, 108, 76-82.
20. Robinson, I. C., Clark, R. G., and Carlsson, L. M. (1987) Insulin, IGF-I and growth in diabetic rats. Nature, 326, 549.
21. Phillips, L. S., Pao, C. I., and Villafuerte, B. C. (1998) Molecular regulation of insulin-like growth factor-I and its principal binding protein, IGFBP-3. Prog. Nucleic Acid Res. Mol. Biol., 60, 195-265.
22. Maes, M., Underwood, L. E., and Ketelslegers, J. M. (1986) Low serum somatomedin-C in insulin-dependent diabetes: Evidence for a postreceptor mechanism. Endocrinology, 118, 377-382.
23. Flyvbjerg, A., Bornfeldt, K. E., Orskov, H., and Arnqvist, H. J. (1991) Effect of insulin-like growth factor I infusion on renal hypertrophy in experimental diabetes mellitus in rats. Diabetologia, 34, 715-720.
24. Landau, D., Chin, E., Bondy, C., Domene, H., Roberts, C. T. J., Gronbaek, H., Flyvbjerg, A., and LeRoith, D. (1995) Expression of insulin-like growth factor binding proteins in the rat kidney: Effects of long-term diabetes. Endocrinology, 136, 1835-1842.
25. Flyvbjerg, A. (2000) Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease. Diabetologia, 43, 1205-1223.
26. Keynan, S., Hirshberg, B., Levin-Iaina, N., Wexler, I. D., Dahan, R., Reinhartz, E., Ovadia, H., Wollman, Y., Chernihovskey, T., Iaina, A., and Raz, I. (2000) Renal nitric oxide production during the early phase of experimental diabetes mellitus. Kidney Int., 58, 740-747.